Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
EDITORIAL Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention.
CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.
Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.
A modality-agnostic patch-based technique for lesion filling in multiple sclerosis.
Pallidal and caudate volumes correlate with walking function in multiple sclerosis.
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
[Treatment and prognosis of neuromyelitis optica(NMO)].
Elevated CSF histamine levels in multiple sclerosis patients.
Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs.
Acute-onset multifocal motor neuropathy (AMMN):how we meet the diagnosis.
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.
[The role of the solar and geomagnetic activity in the etiology of multiple sclerosis: a review of the literature and prospects of research].
Characterization of Microcirculation in Multiple Sclerosis Lesions by Dynamic Texture Parameter Analysis (DTPA).
Is MS an inflammatory or primary degenerative disease?
Exercising away the blues: can it help multiple sclerosis-related depression?
Erratum: the neuroradiology journal 26: 3-7, 2013. Diffusion tensor magnetic resonance imaging in patients with multiple sclerosis and its relationship with disability.
Clinical Guidance of Community Physiotherapists Regarding People with MS: Professional Development and Continuity of Care.
Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations.
Migraine Headaches And Pain With Neuropathic Characteristics: Comorbid Conditions In Patients With Multiple Sclerosis.
Psychiatric diagnoses and cognitive impairment in pediatric multiple sclerosis.
Serum analysis by 1H Nuclear Magnetic Resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
Deep brain stimulation for pain.
Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus.
Cerebrospinal fluid pleocytosis in multiple sclerosis patients with lesions showing reduced diffusion.
Progressive multiple sclerosis does not associate with rs996343 and rs2046748.
Pages
« first
‹ previous
…
602
603
604
605
606
607
608
609
610
…
next ›
last »